Skip to content

Experimental study on the effect of Taxisan on colonization of Staphylococcus aureus in skin lesions of atopic dermatitis in vivo and in vitro

Experimental study on the effect of Taxisan on colonization of Staphylococcus aureus in skin lesions of atopic dermatitis in vivo and in vitro

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004582
Enrollment
Unknown
Registered
2021-03-16
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Sponsors

Shaanxi Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of atopic dermatitis established in accordance with the diagnostic criteria of Hanifin and Rajka, as well as in accordance with the syndrome diagnostic criteria within TCM. 2. SCORAD score <= 40. 3. Aged between 7 and 60 years. 4. Participant or guardian has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe primary diseases, such as cardiovascular disease, respiratory diseases, liver and kidney disease, blood system diseases, tumors and mental illness, etc.; 2. Known experimental drug allergies; 3. ALT or AST exceeded the upper limit of the normal range 2 times, and the BUN value exceeded the upper limit of the normal range 1.5 times at the screening period. 4. Pregnancy and breastfeeding or plan to get pregnant within 3 months. 5. Nearly 4 weeks system using immunomodulatory or immunosuppressive. Nearly 2 weeks system or local using antibiotics. Nearly 2 weeks system using antihistamines. Nearly 2 weeks using PUVA, UVA or UVB. Nearly 2 weeks local using tacrolimus or glucocorticoids. 6. Participating in other clinical trials or have participated in other clinical trials within 1 month. 7. Other reasons the researchers considered unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Scoring Atopic Dermatitis Index;

Secondary

MeasureTime frame
investigator's global assessment;Dermatology Life Quality Index;Colonization amount of Staphylococcus aureus;Visual Analogue Scale/Score;

Countries

China

Contacts

Public ContactYiding Zhao

Shaanxi Traditional Chinese Medicine Hospital

zhaoyiding2083@126.com+86 15829283632

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026